Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 1
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
90 days
×
Clear all
Filters
3
NCT07161414
2026-03-17
ARTEMIDE-subQ
AstraZeneca
Phase 1
Recruiting
40 enrolled
NCT05853367
2026-03-13
MK-0472-001
Merck Sharp & Dohme LLC
Phase 1
Recruiting
178 enrolled
NCT05017012
2026-01-08
MK-3475A-C18
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
72 enrolled
NCT06460961
2025-12-31
MK-6837-001
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
168 enrolled